Oxurion NV (FRA:TG40) Days Payable: 0.00 (As of Dec. 2025)


What is Oxurion NV Days Payable?

Oxurion NV FRA:TG40 Days Payable is 0.00 as of Dec. 2025. The stock has 7 warning signs investors should review. Among 699 Biotechnology companies, Oxurion NV ranks worse than 143061.37% on this metric.

Oxurion NV's average Accounts Payable for the six months ended in Dec. 2025 was €3.62 Mil. Oxurion NV's Cost of Goods Sold for the six months ended in Dec. 2025 was €0.00 Mil.

The historical rank and industry rank for Oxurion NV's Days Payable or its related term are showing as below:

During the past 13 years, Oxurion NV's highest Days Payable was 40154.24. The lowest was 267.09. And the median was 2789.98.

FRA:TG40's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 112.84
* Ranked among companies with meaningful Days Payable only.

Oxurion NV's Days Payable declined from Dec. 2024 (61,034.08) to Dec. 2025 (0.00). It may suggest that Oxurion NV accelerated paying its suppliers.

Oxurion NV Days Payable Historical Data

* Premium members only.

The historical data trend for Oxurion NV's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxurion NV Days Payable Chart

Oxurion NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,789.98 3,564.26 11,455.03 40,154.24 0.00

Oxurion NV Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13,535.81 34,062.32 61,034.08 0.00 0.00

FRA:TG40 vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Oxurion NV's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxurion NV Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxurion NV's Days Payable distribution charts can be found below:

* The bar in red indicates where Oxurion NV's Days Payable falls into.


Oxurion NV Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Oxurion NV's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (4.521 + 2.535) / 2 ) / 0*365
=3.528 / 0*365
=N/A

Oxurion NV's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (4.699 + 2.535) / 2 ) / 0*365 / 2
=3.617 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Oxurion NV (FRA:TG40) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Oxurion NV and its competitors. Over the past decade, Oxurion NV's Days Payable has ranged from 267.09 to 40,154.24. According to the industry distribution chart, Oxurion NV ranks #999999 out of 699 companies in the Biotechnology industry.
Is Oxurion NV's Days Payable too high?
Oxurion NV's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 267.09 to a high of 40,154.24. Based on the distribution chart, Oxurion NV ranks #999999 out of 699 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Oxurion NV's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Oxurion NV ranks #999999 out of 699 companies for Days Payable. This places Oxurion NV in the lower half of its industry. The industry median Days Payable is 112.84. Historically, Oxurion NV's own Days Payable has ranged from 267.09 to 40,154.24 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 699 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Oxurion NV and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oxurion NV's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxurion NV stock overvalued right now?
Oxurion NV (FRA:TG40) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Oxurion NV (FRA:TG40), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oxurion NV Business Description

Other Exchanges TG40:GermanyOXUR:Belgium
Address Gaston Geenslaan 1, Leuven, BEL, B-3001
Oxurion NV is a holding company specializing in acquiring and integrating clinical research services companies (CROs) covering the full clinical research value chain across Europe.